GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM12935
Query DataSets for GSM12935
Status
Public on Nov 30, 2003
Title
Contralateral Control 1
Sample type
RNA
Source name
Rat Lacrimal Gland
Organism
Rattus norvegicus
Extracted molecule
total RNA
Description
Control Lacrimal Gland ipsilateral to the Experimental Side-7 days after greater superficial petrosal nerve sectioning.
Submission date
Nov 19, 2003
Last update date
May 28, 2005
Contact name
Doan Nguyen
E-mail(s)
[email protected]
Phone
504-412-1200
Organization name
LSU Eye Center/LSUHSC
Department
Street address
City
New Orleans
State/province
LA
ZIP/Postal code
70112
Country
USA
Platform ID
GPL85
Series (1)
GSE844
Control LG vs Px LG
Data table header descriptions
ID_REF
VALUE_RAW
unscaled value
Detection p-value
VALUE
scaled value
ABS_CALL
Data table
ID_REF
VALUE_RAW
Detection p-value
VALUE
ABS_CALL
AFFX-MurIL2_at
1
0.699394
101.1
A
AFFX-MurIL10_at
7.8
0.250796
769.1
A
AFFX-MurIL4_at
3.2
0.617401
313
A
AFFX-MurFAS_at
3.9
0.544587
381.9
A
AFFX-BioB-5_at
93.2
0.000297
9175.1
P
AFFX-BioB-M_at
353.1
0.000044
34742.4
P
AFFX-BioB-3_at
169.9
0.00006
16720.8
P
AFFX-BioC-5_at
490.2
0.00006
48234.7
P
AFFX-BioC-3_at
324.8
0.000044
31965.4
P
AFFX-BioDn-5_at
407.3
0.000044
40081.1
P
AFFX-BioDn-3_at
1899.3
0.000044
186897.8
P
AFFX-CreX-5_at
3128.7
0.000044
307867.5
P
AFFX-CreX-3_at
5010.4
0.000044
493031.4
P
AFFX-BioB-5_st
8.4
0.440646
830.7
A
AFFX-BioB-M_st
14.4
0.078002
1413
A
AFFX-BioB-3_st
2.7
0.659339
262.5
A
AFFX-BioC-5_st
2.5
0.783476
246.7
A
AFFX-BioC-3_st
8.6
0.382599
845.4
A
AFFX-BioDn-5_st
4.9
0.205732
481.3
A
AFFX-BioDn-3_st
27.9
0.050229
2746.3
M
Total number of rows:
8799
Table truncated, full table size
297 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|